Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Rydell

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Blood|February 1, 1979
Neutrophilic nonspecific esteraseR E Rydell
The Journal of the Florida Medical Association|November 1, 1976
Stereotactic percutaneous cordotomyR E Rydell
Cancer|July 1, 1980
Richter's syndrome in chronic lymphocytic leukemiaK Foucar, R E Rydell
Minnesota Medicine|October 1, 1981
Richter's syndrome: a blastic transformation of chronic lymphocyte leukemiaK Foucar, R E Rydell
Minnesota Medicine|November 1, 1971
Dandy-Walker malformation: association with syringomyeliaG S Baker, R E Rydell
Archives of Otolaryngology (Chicago, Ill. : 1960)|July 1, 1971
Arnold-Chiari malformation. Neuro-otologic symptomsR E Rydell, J L Pulec
Journal of the National Cancer Institute|February 1, 1978
Lack of susceptibility of F344 rats to mammary tumor induction by topically applied fluorenylacetohydroxamic acids and their acetatesD Malejka-Giganti, R E Rydell
The New England Journal of Medicine|July 19, 1973
Frequent association of IgMlambda with crystalline inclusions in chronic lymphatic leukemic lymphocytesC Clark, R E Rydell, M E Kaplan
Cancer Research|February 1, 1975
The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophilesY Yost, H R Gutmann, R E Rydell
Journal of the National Cancer Institute|June 1, 1980
Inhibitory effect of disulfiram on rat mammary tumor induction by N-2-fluorenylacetamide and on its metabolic conversion to N-hydroxy-N-2-fluorenylacetamideD Malejka-Giganti, R C McIver, R E Rydell
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Blood|February 1, 1979
Neutrophilic nonspecific esteraseR E Rydell
The Journal of the Florida Medical Association|November 1, 1976
Stereotactic percutaneous cordotomyR E Rydell
Cancer|July 1, 1980
Richter's syndrome in chronic lymphocytic leukemiaK Foucar, R E Rydell
Minnesota Medicine|October 1, 1981
Richter's syndrome: a blastic transformation of chronic lymphocyte leukemiaK Foucar, R E Rydell
Minnesota Medicine|November 1, 1971
Dandy-Walker malformation: association with syringomyeliaG S Baker, R E Rydell
Archives of Otolaryngology (Chicago, Ill. : 1960)|July 1, 1971
Arnold-Chiari malformation. Neuro-otologic symptomsR E Rydell, J L Pulec
Journal of the National Cancer Institute|February 1, 1978
Lack of susceptibility of F344 rats to mammary tumor induction by topically applied fluorenylacetohydroxamic acids and their acetatesD Malejka-Giganti, R E Rydell
The New England Journal of Medicine|July 19, 1973
Frequent association of IgMlambda with crystalline inclusions in chronic lymphatic leukemic lymphocytesC Clark, R E Rydell, M E Kaplan
Cancer Research|February 1, 1975
The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophilesY Yost, H R Gutmann, R E Rydell
Journal of the National Cancer Institute|June 1, 1980
Inhibitory effect of disulfiram on rat mammary tumor induction by N-2-fluorenylacetamide and on its metabolic conversion to N-hydroxy-N-2-fluorenylacetamideD Malejka-Giganti, R C McIver, R E Rydell
Pageof 3